Viewing data from:

NORTRIPTYLINE HYDROCHLORIDE

ANDA

NORTRIPTYLINE HYDROCHLORIDE | A075520 | TARO PHARMACEUTICAL INDUSTRIES LTD

4 strengths0 unique patents0 unique exclusivities

API Supply Chain3 active DMFs2 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

SIGMA ALDRICH IRELAND LTDNORTRIPTYLINE HYDROCHLORIDE

DMF 74141988

VASUDHA PHARMA CHEM LTDNORTRIPTYLINE HYDROCHLORIDE USP

DMF 319742017

RL FINE CHEM PVT LTDNORTRIPTYLINE HYDROCHLORIDE

DMF 332272018

DSM PHARMA CHEMICALS SOUTH HAVEN INCInactiveNORTRIPTYLINE HYDROCHLORIDE

DMF 83881990

ZYDUS LIFESCIENCES LTDInactiveNORTRIPTYLINE HYDROCHLORIDE USP

DMF 213302008

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
May 8, 2000	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (4)

Sort:

#001 — EQ 50MG BASE

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: May 8, 2000

No patent or exclusivity listings for this strength.

#002 — EQ 75MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: May 8, 2000

#003 — EQ 25MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: May 8, 2000

#004 — EQ 10MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: May 8, 2000